Literature DB >> 12864869

Hypertensive risk factors in kidney disease in African Americans.

Agnes B Fogo1.   

Abstract

African Americans with hypertension more commonly develop renal insufficiency compared to Caucasians. The African American Study of Kidney Disease (AASK) included a renal biopsy pilot study that demonstrated that the clinical diagnosis of so-called hypertensive nephrosclerosis in these African American patients indeed was accurate. This biopsy study demonstrated extensive global glomerulosclerosis, far exceeding that expected for patients' age. We further compared our clinically indicated renal biopsies to determine if any phenotypic differences were present in hypertensive nephrosclerosis in African Americans versus Caucasians. These studies point to an excess of the solidified type of global glomerulosclerosis (GS) (also called "decompensated benign nephrosclerosis") in African Americans compared to more obsolescent type GS in Caucasians. We speculate that these phenotypic differences might reflect differing mechanisms of tissue injury in hypertensive African Americans versus Caucasians, and discuss possible contributors to this injury.

Entities:  

Mesh:

Year:  2003        PMID: 12864869     DOI: 10.1046/j.1523-1755.63.s83.5.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  7 in total

1.  Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure.

Authors:  Aaron J Polichnowski; Limin Lu; Allen W Cowley
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

2.  Models of chronic kidney disease.

Authors:  Hai-Chun Yang; Yiqin Zuo; Agnes B Fogo
Journal:  Drug Discov Today Dis Models       Date:  2010

3.  Cells derived from young bone marrow alleviate renal aging.

Authors:  Hai-Chun Yang; Michele Rossini; Li-Jun Ma; Yiqin Zuo; Ji Ma; Agnes B Fogo
Journal:  J Am Soc Nephrol       Date:  2011-09-30       Impact factor: 10.121

4.  Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control.

Authors:  Adriana M Hung; Christianne L Roumie; Robert A Greevy; Xulei Liu; Carlos G Grijalva; Harvey J Murff; Marie R Griffin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-06       Impact factor: 2.890

5.  Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension.

Authors:  Tang-Dong Liao; Xiao-Ping Yang; Yun-He Liu; Edward G Shesely; Maria A Cavasin; William A Kuziel; Patrick J Pagano; Oscar A Carretero
Journal:  Hypertension       Date:  2008-06-09       Impact factor: 10.190

6.  The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action?

Authors:  Cristiana Catena; GianLuca Colussi; Leonardo A Sechi
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-01-22       Impact factor: 3.738

7.  Mechanisms of progression of chronic kidney disease.

Authors:  Agnes B Fogo
Journal:  Pediatr Nephrol       Date:  2007-07-24       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.